Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12404347
Glucuronoxylomannan (GXM) receptor chimeric antigen receptors and use thereof
granted -
US 12403167
Phenylethanoid glycoside extract from Acanthus ilicifolius L., preparation method thereof and use as anti-liver injury medicament
granted -
US 12404533
Bioconjugate vaccines' synthesis in prokaryotic cell lysates
granted -
US 12403136
Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof
granted -
US 12404505
Delivery of a gene-editing system with a single retroviral particle and methods of generation and use
granted -
US 12403154
Administration of sting agonist and checkpoint inhibitors
granted -
US 12403200
Methods and compositions for treating autoimmune diseases
granted -
US 12403093
Methods for production of MSC-derived exosomes
granted -
US 12403196
Ras inhibitors
granted -
US 12403087
Topical antiviral compositions, delivery systems, and methods of using the same
granted -
US 12398194
Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface
granted -
US 12398123
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
granted -
US 12397066
Delivery of gene therapy treatments
granted -
US 12397028
Adoptive cellular therapy
granted -
US 12397058
Metabolically stable prodrugs
granted -
US 12397062
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12397034
Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesis and inhibiting senescence of brain neurons
granted -
US 12398131
Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof
granted -
US 12398154
Azaquinazoline pan-KRas inhibitors
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted -
US 12398140
Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia
granted -
US 12398178
Collections of peptides, peptide agents, and methods of use thereof
granted -
US 12398197
Antibodies with engineered CH2 domains, compositions thereof and methods of using the same
granted -
US 12398212
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.